Drug Profile
C1-esterase inhibitor - BioGenius
Alternative Names: Bicizar; Human plasma derived C1-esterase inhibitor; Human purified derived C1-esterase inhibitorLatest Information Update: 11 Oct 2021
Price :
$50
*
At a glance
- Originator BioGenius
- Class
- Mechanism of Action Complement C1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Sepsis; Septic shock
Most Recent Events
- 11 Oct 2021 No development reported - Phase-III for Sepsis in Russia (IV)
- 11 Oct 2021 No development reported - Phase-III for Septic shock in Russia (IV)
- 05 Sep 2018 Phase III development is ongoing in Russia